<DOC>
	<DOCNO>NCT02503449</DOCNO>
	<brief_summary>The purpose study:1.Improve understanding risk factor pulmonary cryptococcosis ; 2.Improve awareness pulmonary cryptococcosis clinical imaging manifestation ; 3.Grasp pulmonary cryptococcosis patient clinical imaging manifestation different condition ; 4.Learn antibacterial activity antifungal drug cryptococcosis China .</brief_summary>
	<brief_title>Clinical Trial Pulmonary Cryptococcosis China</brief_title>
	<detailed_description>1 . Patients correspond inclusion criterion obtain informed consent include research department respiration ward cooperative hospital . 2 . Relevant case report form create study . 3 . Basic information age , weight height record select cases.Clinical manifestation , risk factor , laboratory examination , image examination , etiological examination histopathological examination also record select case case report forms.In addition , antifungal treatment record include name , dose , time start treatment terminate treatment.Causes terminate treatment curative effect evaluation analyse . 4 . Statistical analysis .</detailed_description>
	<mesh_term>Cryptococcosis</mesh_term>
	<criteria>Patients possess clinical imaging manifestation pulmonary infection , result ( one follow condition ) microbiological examination histopathologic examination 1 . Cryptococcal capsular polysaccharide antigen blood pleural effusion positive 2 . Cryptococcus（fungus culture ) discover low respiratory tract specimens 3 . Cryptococcus（pleural effusion culture ) discover pleural effusion collect sterile condition 4 . Cryptococcus（pus culture ) discover pus smear pulmonary infection disseminate infection patient 5 . Cryptococcus（blood culture ) discover microscopy specimen blood smear 6 . Cryptococcus discover culture pathological tissue specimens aseptic condition 7 . Cryptococcal capsular budding yeast inflammatory reaction discover histopathological examination , cell pathology examination microscopic examination aseptic condition 1 . Patients suffer acquire immune deficiency syndrome 2 . Patients legal guardian request withdraw clinical research</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Pulmonary Cryptococcosis</keyword>
</DOC>